Resolution of the oedema associated with allergic pulmonary inflammation in rats assessed noninvasively by magnetic resonance imaging

British Journal of Pharmacology

Volumn 140, Issue 2, 2003, Pages 239-246

  Tigani, Bruno ^a   Cannet, Catherine ^b   Zurbrügg, Stefen ^a   Schaeublin, Elisabeth ^c   Mazzoni, Lazzaro ^c   Fozard, John R ^c   Beckmann, Nicolau ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Transplantation Research   (Switzerland)

^c Respiratory Diseases Department   (Switzerland)

Author keywords

Allergen; Aquaporin; Asthma; Lung; Magnetic resonance imaging (MRI); Oedema; Oedema clearance; Ovalbumin; Phosphodiesterase (PDE); Phosphodiesterase 4 inhibitor; Rat

Indexed keywords

4 (8 BENZ[1,2,5]OXADIAZOL 5 YL[1,7]NAPHTHYRIDIN 6 YL)BENZOIC ACID; BUDESONIDE; GLUCOCORTICOID; OVALBUMIN; PHOSPHODIESTERASE IV INHIBITOR; UNCLASSIFIED DRUG;

ALLERGIC PNEUMONITIS; ANIMAL MODEL; ARTICLE; BIOLOGICAL MONITORING; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SELECTIVITY; EDEMA; HISTOLOGY; LUNG LAVAGE; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SENSITIZATION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; BUDESONIDE; INFLAMMATION; LEUKOCYTES; LUNG; MAGNETIC RESONANCE IMAGING; MALE; NAPHTHYRIDINES; OVALBUMIN; OXADIAZOLES; PEROXIDASE; PULMONARY EDEMA; RATS; RATS, INBRED BN; RESPIRATORY HYPERSENSITIVITY;

EID: 0141888498     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705429     Document Type: Article

References (21)

1. ACUNA, A.A., GABRIJELCIC, J., URIBE, E.M., RABINOVICH, R., ROCA, J., BARBERA, J.A., CHUNG, K.F. & RODRIGUEZ-ROISIN, R. (2002). Fluticasone propionate attenuates platelet-activating factor-induced gas exchange defects in mild asthma. Eur. Respir. J., 19, 872-878.
2. BECKMANN, N., TIGANI, B., EKATODRAMIS, D., BORER, R., MAZZONI, L. & FOZARD, J.R. (2001). Pulmonary oedema induced by allergen challenge in the rat: non-invasive assessment by magnetic resonance imaging. Magn. Reson. Med., 45, 88-95.
3. BEITZ, E. & SCHULTZ, J.E. (1999). The mammalian aquaporin water channel family: a promising new drug target. Curr. Med. Chem., 6, 457-467.
4. BERTHIAUME, Y., STAUB, N.C. & MATTHAY, M.A. (1987). Beta-adrenergic agonists increase lung liquid clearance in anaesthetized sheep. J. Clin. Invest., 79, 335-343.
5. +-ATPase isozymes by protein kinases and arachidonic acid. Arch. Biochem. Biophys., 359, 139-150.
6. BUNDSCHUH, D.S., ELTZE, M., BARSIG, J., WOLLIN, L., HATZELMANN, A. & BEUME, R. (2001). In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. J. Pharmacol. Exp. Ther., 297, 280-290.
7. CHARRON, P.D., FAWLEY, J.P. & MARON, M.B. (1999). Effect of epinephrine on alveolar liquid clearance in the rat. J. Appl. Physiol., 87, 611-618.
8. CHEN, X.-J., EATON, D.C. & JAIN, L. (2002). Adrenergic regulation of amiloride-sensitive lung sodium channels. Am. J. Physiol. Lung Cell. Mol. Physiol., 282, L609-L620.
9. GOODMAN, B.E., ANDERSON, J.L. & CLEMENS, J.W. (1989). Evidence for regulation of sodium transport from airspace to vascular space by cAMP. Am. J. Physiol. Lung Cell. Mol. Physiol., 257, L86-L93.
10. JEFFERY, P.K., WARDLAW, A.J., NELSON, F.C., COLLINS, J.V. & KAY, A.B. (1989). Bronchial biopsies in asthma: an ultrastructural quantitative study and correlation with hyperreactivity. Am. Rev. Respir. Dis., 140, 1745-1753.
11. + transport across alveolar epithelial cells involves activation of apical Cl- channels. Am. J. Physiol. Cell. Physiol., 275, C1610-C1620.
12. KIRBY, J.G., HARGREAVE, F.E., GLEICH, G.J. & O'BYRNE, P.M. (1987). Bronchoalveolar lavage profiles of asthmatic and non-asthmatic subjects. Am. Rev. Respir. Dis., 136, 379-383.
13. LEFORT, J., SINGER, M., LEDUC, D., RENESTO, P., NAHORI, M.A., HUERRE, M., CREMINON, C., CHIGNARD, M. & VARGAFTIG, B.B. (1998). Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs. J. Immunol., 161, 474-480.
14. MATTHAY, M.A., FOLKESSON, H.G. & CLERICI, C. (2002). Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol. Rev., 82, 569-600.
15. PAVORD, I.D., PIZZICHINI, M.M., PIZZICHINI, E. & HARGREAVE, F.E. (1997). The use of induced sputum to investigate airway inflammation. Thorax, 52, 498-501.
16. SAKUMA, T., FOLKESSON, H.G., SUZUKI, S., OKANIWA, G., FUJIMURA, S. & MATTHAY, M.A. (1997). Beta-adrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs. Am. J. Respir. Crit. Care Med., 155, 506-512.
17. SOMMER, A., VERAART, J., NEUMANN, M. & KESSELS, A. (1998). Evaluation of the vasoconstrictive effects of topical steroids by laser-Doppler-perfusion-imaging. Acta Derm. Venereol., 78, 15-18.
18. TIGANI, B., SCHAEUBLIN, E., SUGAR, R., JACKSON, A.D., FOZARD, J.R. & BECKMANN, N. (2002). Pulmonary inflammation monitored non-invasively by MRI in freely breathing rat. Biochem. Biophys. Res. Commun., 292, 216-221.
19. TOWNE, J.E., KRANE, C.M., BACHURSKY, C.J. & MENON, A.G. (2001). Tumor necrosis factor-a inhibits aquaporin 5 expression in mouse lung epithelial cells. J. Biol. Chem., 276, 18657-18664.
20. TRIFILIEFF, A., WYSS, D., WALKER, C., MAZZONI, L. & HERSPERGER, R. (2002). Pharmacological profile of a novel phosphodiesterase 4 inhibitor, 4-(8-benzo[1,2,5]oxadiazol-5-yl-[1,7] naphthyridin-6-yl)-benzoic acid (NVP-ABE171), a 1,7-naphthyridine derivative, with anti-inflammatory activities. J. Pharmacol. Exp. Ther., 301, 241-248.
21. UNDERWOOD, D.C., BOCHNOWICZ, S., OSBORN, R.R., KOTZER, C.J., LUTTMANN, M.A., HAY, D.W.P., GORYCKI, P.O., CHRISTENSEN, S.B. & TORPHY, T.J. (1998). Antiasthmatic activity of the second-generation phosphodiesterase 4 (PDE4) inhibitor SB 207499 (Ariflo) in the guinea pig. J. Pharmacol. Exp. Ther., 298, 988-995.